论文信息 - Long-term bosutinib (BOS) in patients (pt) with chronic phase (CP) chronic myeloid leukemia (CML) after prior imatinib (IM) failure. - 字舞流文

Long-term bosutinib (BOS) in patients (pt) with chronic phase (CP) chronic myeloid leukemia (CML) after prior imatinib (IM) failure.

T. Brümmendorf | H. Kantarjian | J. Cortes | J. Lipton | M. Zeremski | H. Khoury | E. Leip | C. Gambacorti-Passerini | Dong-Wook Kim | P. Schafhausen | N. Bardy-Bouxin | M. Shapiro